Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank92
3Y CAGR+67.4%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+67.4%/yr
vs +84.7%/yr prior
Acceleration
-17.2pp
Decelerating
Percentile
P92
Near historical high
vs 3Y Ago
4.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $20.79M | -28.5% |
| 2024 | $29.09M | +74.0% |
| 2023 | $16.72M | +277.3% |
| 2022 | $4.43M | +1306.3% |
| 2021 | $315000.00 | +194.0% |
| 2020 | $-335000.00 | -416.0% |
| 2019 | $106000.00 | -72.2% |
| 2018 | $381000.00 | +1805.0% |
| 2017 | $20000.00 | +112.0% |
| 2016 | $-166000.00 | - |